Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Shukra Pharmaceuticals Financial Results

Shukra Pharmaceuticals approved FY26 audited financial results and recommended a 1% final dividend. The board also allotted 17.35 lakh equity shares upon warrant conversion.

Source

BSE filing, NSE: SHUKRAPHAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Shukra Pharmaceuticals Ltd: key numbers

Share price
₹74.95
Market cap
₹3,317 Cr
Revenue (annual)
₹56.73 Cr
Net profit (annual)
₹22.06 Cr
P/E (TTM)
97.6×Sector 45.9×
Promoter holding
51.15%+0.19% QoQ
FII holding
0.43%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shukra Pharmaceuticals Ltd

All →

Other financial results announcements

All →
21:55 IST NSE
Financial ResultsJay Jalaram Technologies Ltd KORE

Jay Jalaram Technologies H1 FY27 Results: Net Profit ₹9.3 Cr, Up 78.8% YoY

Jay Jalaram Technologies Ltd reported revenue from operations of ₹655.8 Cr (+83.7% YoY) and net profit of ₹9.3 Cr (+78.8% YoY) for H1 FY27.

Key figure
Net profit ₹9.3 Cr · +78.8% YoY